How has the respiratory syncytial virus (rsv) diagnostics market evolved, and where is it heading next?
The respiratory syncytial virus (RSV) diagnostics market size has grown rapidly in recent years. It will grow from $1.01 billion in 2024 to $1.12 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to rising adoption of point-of-care diagnostics, government initiatives to improve RSV diagnostics, rising incidence of respiratory diseases in children, growth in hospital-acquired infections, and rising demand for non-invasive diagnostic methods.
The respiratory syncytial virus (RSV) diagnostics market size is expected to see rapid growth in the next few years. It will grow to $1.68 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the increasing prevalence of respiratory syncytial virus (RSV) infections, rising awareness about RSV diagnostics, expanding healthcare infrastructure, increasing healthcare spending globally, and growth in the elderly population. Major trends in the forecast period include advances in molecular diagnostic technologies, technological advancements in diagnostic devices, adoption of rapid diagnostic tests (RDTs), expansion of diagnostic test portfolios by companies, and advances in genetic and proteomic diagnostics.
Get Your Free Sample of The Global Respiratory Syncytial Virus (RSV) Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21273&type=smp
What are the key drivers behind the rapid expansion of the respiratory syncytial virus (rsv) diagnostics market?
The rising prevalence of respiratory diseases is expected to drive the growth of the respiratory syncytial virus (RSV) diagnostics market going forward. Respiratory diseases are a group of disorders affecting the airways and lungs, impairing breathing and oxygen exchange, and include conditions such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and respiratory infections. The prevalence of respiratory diseases is rising due to factors such as increasing air pollution, smoking, climate change, urbanization, and the growing prevalence of infections and chronic conditions like asthma and COPD. Respiratory syncytial virus (RSV) diagnostics is essential for respiratory diseases to enable accurate and timely identification of RSV infections, allowing for appropriate treatment, management, and prevention of severe complications, especially in vulnerable populations. For instance, in November 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, an estimated 2.8 million people (11% of the population) in Australia were living with asthma in 2022. Asthma accounted for 2.5% of the total disease burden and 35% of the burden from all respiratory conditions in 2023. It was the underlying cause of 467 deaths in 2022, equating to 1.8 deaths per 100,000 people and representing 0.2% of all deaths. Therefore, the rising prevalence of respiratory diseases is fueling the growth of the respiratory syncytial virus (RSV) diagnostics market.
What is the segmentation for the respiratory syncytial virus (rsv) diagnostics market?
The respiratory syncytial virus (RSV) diagnostics market covered in this report is segmented –
1) By Product Type: Kits And Assays, Instruments, Reagents, Other Product Types
2) By Technology: Molecular Diagnostics, Immunoassays, Rapid Antigen Detection Tests, Other Technologies
3) By Sample Type: Nasal Swabs, Throat Swabs, Bronchoalveolar Lavage
4) By End User: Hospitals, Diagnostic Laboratories, Home Care Settings, Other End Users
Subsegments:
1) By Kits And Assays: Rapid Antigen Detection Kits, PCR-based Assays, Serological Assays
2) By Instruments: PCR Analyzers, Immunoassay Analyzers
3) By Reagents: PCR Reagents, Antibody Reagents, Enzyme Reagents
4) By Other Product Types: Sample Collection Devices, Transport Media
Order your report now for swift delivery
Who are the most influential companies in the respiratory syncytial virus (rsv) diagnostics market?
Major companies operating in the respiratory syncytial virus (RSV) diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Merck KGaA, Becton, Dickinson, and Company, Quest Diagnostics Incorporated, Hologic Inc., BIOMÉRIEUX SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Acon Laboratories Inc., Cepheid Inc., Meridian Bioscience Inc., Seegene Inc., LumiraDx Ltd., Sekisui Diagnostics Ltd., Boditech Med Inc., Trinity Biotech plc, R-Biopharm AG, GeneTex Inc., Creative Diagnostics, Certest Biotec S.L., Clarity Diagnostics LLC, Genes 2Me LLP, Coris BioConcept S.A.
What are the most influential trends expected to drive the respiratory syncytial virus (rsv) diagnostics market forward?
Major companies operating in the respiratory syncytial virus (RSV) diagnostics market are developing innovative products, such as respiratory virus combination testing, to provide accurate and efficient solutions for customers. Respiratory virus combination testing is a diagnostic method that simultaneously detects multiple respiratory viruses, such as influenza, respiratory syncytial virus (RSV), and others, in a single sample to aid in the identification of viral infections. For instance, in January 2023, Sonora Quest Laboratories, a US-based clinical laboratory testing company, launched the COVID-19, RSC, and influenza diagnostic test. This molecular diagnostic test provides a qualitative, multi-target analysis using a single patient sample to detect COVID-19, respiratory syncytial virus (RSV), and influenza. By combining these three virus tests into one, it streamlines the testing process and reduces the need for multiple samples. The ability to quickly identify all three infections helps healthcare providers make faster treatment decisions, potentially improving patient outcomes. Additionally, this test can contribute to slowing the spread of these viruses, reducing the risk of transmission to others.
What are the major regional insights for the respiratory syncytial virus (rsv) diagnostics market, and which region holds the top position?
North America was the largest region in the respiratory syncytial virus (RSV) diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory syncytial virus (RSV) diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Respiratory Syncytial Virus (RSV) Diagnostics Market Report 2025 Offer?
The respiratory syncytial virus (rsv) diagnostics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Respiratory syncytial virus (RSV) diagnostics refers to the tests and methods used to detect the presence of RSV in patients, typically through respiratory samples like nasal swabs or throat swabs. It is used for identifying RSV infections, which can cause respiratory illness in infants, young children, and the elderly, to guide treatment and management.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21273
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
